111 related articles for article (PubMed ID: 26783162)
1. Cost-effectiveness of whole-body bone scans in the pre-liver transplant assessment of patients with hepatocellular carcinoma in Southern Brazil.
Rodríguez S; Balbinotto Neto G; Kiss G; Brandão A;
Clin Transplant; 2016 Apr; 30(4):399-406. PubMed ID: 26783162
[TBL] [Abstract][Full Text] [Related]
2. Liver transplantation in cirrhotic patients with small hepatocellular carcinoma: an analysis of pre-operative imaging, explant histology and prognostic histologic indicators.
Bhattacharjya S; Bhattacharjya T; Quaglia A; Dhillon AP; Burroughs AK; Patch DW; Tibballs JM; Watkinson AF; Rolles K; Davidson BR
Dig Surg; 2004; 21(2):152-9; discussion 159-60. PubMed ID: 15166485
[TBL] [Abstract][Full Text] [Related]
3. Cost-effectiveness of screening for recurrent hepatocellular carcinoma after liver transplantation.
Ladabaum U; Cheng SL; Yao FY; Roberts JP
Clin Transplant; 2011; 25(2):283-91. PubMed ID: 20156221
[TBL] [Abstract][Full Text] [Related]
4. Direct costs of care for hepatocellular carcinoma in patients with hepatitis C cirrhosis.
Tapper EB; Catana AM; Sethi N; Mansuri D; Sethi S; Vong A; Afdhal NH
Cancer; 2016 Mar; 122(6):852-8. PubMed ID: 26716758
[TBL] [Abstract][Full Text] [Related]
5. Liver transplantation for hepatocellular carcinoma: the Baylor experience.
Onaca N; Klintmalm GB
J Hepatobiliary Pancreat Sci; 2010 Sep; 17(5):559-66. PubMed ID: 19727543
[TBL] [Abstract][Full Text] [Related]
6. [Diagnostic value of multislice spiral CT and MRI in detection of tumor recurrence after liver transplantation for hepatocellular carcinoma].
Wang J; He BJ; Jiang ZB; Zhang YQ; Shan H; Xiao R; Zhang JS; Luo L; Kuang SC; Chen GH; Yang Y
Zhonghua Zhong Liu Za Zhi; 2009 Sep; 31(9):691-6. PubMed ID: 20021867
[TBL] [Abstract][Full Text] [Related]
7. Benefit of Treating Hepatocellular Carcinoma Recurrence after Liver Transplantation and Analysis of Prognostic Factors for Survival in a Large Euro-American Series.
Sapisochin G; Goldaracena N; Astete S; Laurence JM; Davidson D; Rafael E; Castells L; Sandroussi C; Bilbao I; Dopazo C; Grant DR; Lázaro JL; Caralt M; Ghanekar A; McGilvray ID; Lilly L; Cattral MS; Selzner M; Charco R; Greig PD
Ann Surg Oncol; 2015 Jul; 22(7):2286-94. PubMed ID: 25472651
[TBL] [Abstract][Full Text] [Related]
8. Is radiofrequency ablation applicable for recurrent hepatocellular carcinoma after liver transplantation?
Huang J; Yan L; Wu H; Yang J; Liao M; Zeng Y
J Surg Res; 2016 Jan; 200(1):122-30. PubMed ID: 26277218
[TBL] [Abstract][Full Text] [Related]
9. Is bone scintigraphy indicated in surgical work-up for hepatocellular carcinoma patients?
Witjes CD; Verhoef C; Kwekkeboom DJ; Dwarkasing RS; de Man RA; Ijzermans JN
J Surg Res; 2013 May; 181(2):256-61. PubMed ID: 22831566
[TBL] [Abstract][Full Text] [Related]
10. The role of (18)F-FDG-PET imaging for the selection of liver transplantation candidates among hepatocellular carcinoma patients.
Yang SH; Suh KS; Lee HW; Cho EH; Cho JY; Cho YB; Yi NJ; Lee KU
Liver Transpl; 2006 Nov; 12(11):1655-60. PubMed ID: 16964589
[TBL] [Abstract][Full Text] [Related]
11. [TACE: therapy of the HCC before liver transplantation--experiences].
Herber S; Schneider J; Brecher B; Höhler T; Thelen M; Otto G; Pitton MB
Rofo; 2005 May; 177(5):681-90. PubMed ID: 15871083
[TBL] [Abstract][Full Text] [Related]
12. Financial Burden of Liver Transplant vs Resection for Hepatocellular Carcinoma.
Skill NJ; Butler J; O'Brien DC; Kays JK; Kubal CA; Liangpunsakul S; Ninad N; Maluccio MA
Transplant Proc; 2019; 51(6):1907-1912. PubMed ID: 31399174
[TBL] [Abstract][Full Text] [Related]
13. Pre-transplant therapy for hepatocellular carcinoma is associated with a lower recurrence after liver transplantation.
Lao OB; Weissman J; Perkins JD
Clin Transplant; 2009; 23(6):874-81. PubMed ID: 19453644
[TBL] [Abstract][Full Text] [Related]
14. [Recurrence and metastasis of hepatocellular carcinoma after liver transplantation: single center experiences].
Zheng SS; Chen J; Wang WL; Zhang M; Shen Y; Wu J; Xu X; Yan S
Zhonghua Wai Ke Za Zhi; 2008 Nov; 46(21):1609-13. PubMed ID: 19094751
[TBL] [Abstract][Full Text] [Related]
15. A novel prognostic nomogram accurately predicts hepatocellular carcinoma recurrence after liver transplantation: analysis of 865 consecutive liver transplant recipients.
Agopian VG; Harlander-Locke M; Zarrinpar A; Kaldas FM; Farmer DG; Yersiz H; Finn RS; Tong M; Hiatt JR; Busuttil RW
J Am Coll Surg; 2015 Apr; 220(4):416-27. PubMed ID: 25690672
[TBL] [Abstract][Full Text] [Related]
16. Recurrence of hepatocellular carcinoma after liver transplant: patterns and prognosis.
Roayaie S; Schwartz JD; Sung MW; Emre SH; Miller CM; Gondolesi GE; Krieger NR; Schwartz ME
Liver Transpl; 2004 Apr; 10(4):534-40. PubMed ID: 15048797
[TBL] [Abstract][Full Text] [Related]
17. The role of [18F]fluorodeoxyglucose positron emission tomography imaging in the evaluation of hepatocellular carcinoma.
Wudel LJ; Delbeke D; Morris D; Rice M; Washington MK; Shyr Y; Pinson CW; Chapman WC
Am Surg; 2003 Feb; 69(2):117-24; discussion 124-6. PubMed ID: 12641351
[TBL] [Abstract][Full Text] [Related]
18. Predictive Value of Conventional Ultrasound and Contrast-Enhanced Ultrasound in Early Recurrence of Hepatocellular Carcinoma after Surgical Resection.
Wang Y; Liao J; Qi W; Xie L; Li Y
Ultrasound Med Biol; 2016 May; 42(5):1042-8. PubMed ID: 26803390
[TBL] [Abstract][Full Text] [Related]
19. Preoperative tumour biopsy does not affect the oncologic course of patients with transplantable HCC.
Fuks D; Cauchy F; Fusco G; Paradis V; Durand F; Belghiti J
J Hepatol; 2014 Sep; 61(3):589-93. PubMed ID: 24818985
[TBL] [Abstract][Full Text] [Related]
20. Effectiveness of locoregional therapy before living donor liver transplantation in patients with hepatocellular carcinoma who meet the Milan criteria.
Kim JM; Kwon CH; Joh JW; Choi MS; Lee JH; Koh KC; Paik SW; Kim GS; Kim SJ; Lee SK; Yoo BC
Transplant Proc; 2012 Mar; 44(2):403-8. PubMed ID: 22410028
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
